Literature DB >> 175875

Hypothalamo-pituitary adrenocortical function in the rat after treatment with betamethasone.

J C Buckingham, J R Hodges.   

Abstract

1 Hypothalamo-pituitary-adrenocortical (HPA) activity was suppressed in rats treated with betamethasone. 2 Recovery of normal HPA function occurred after corticosteroid withdrawl. 3 Although corticotrophin release was rapidly restored to its basal rate there was a delay in the return of the normal adrenocorticotrophic response to stress and normal adrenocortical function was evident only after the plasma adrenocorticotrophic hormone had reached 'supra-normal' levels. 4 The physiological significance and possible clinical relevance of the results are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175875      PMCID: PMC1666873          DOI: 10.1111/j.1476-5381.1976.tb07447.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.

Authors:  A L GRABER; R L NEY; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-01       Impact factor: 5.958

2.  Pituitary-adrenal function during corticosteroid therapy.

Authors:  B L TREADWELL; O SALVAGE; E D SEVER; W S COPEMAN
Journal:  Lancet       Date:  1963-02-16       Impact factor: 79.321

3.  The effects of hydrocortisone on the level of corticotrophin in the blood and pituitary glands of adrenalectomized and of stressed adrenalectomized rats.

Authors:  J R HODGES; J VERNIKOS
Journal:  J Physiol       Date:  1960-03       Impact factor: 5.182

4.  Direct and indirect estimation of pituitary adrenocorticotropin reserves in man following adrenal steroid therapy.

Authors:  D A HOLUB; J W JAILER; J I KITAY; A G FRANTZ
Journal:  J Clin Endocrinol Metab       Date:  1959-12       Impact factor: 5.958

5.  The estimation of small amounts of corticosterone in rat plasma.

Authors:  N ZENKER; D E BERNSTEIN
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

6.  Interrelationships of pituitary and plasma corticotrophin and plasma corticosterone during adrenocortical regeneration in the rat.

Authors:  J C Buckingham; J R Hodges
Journal:  J Endocrinol       Date:  1975-12       Impact factor: 4.286

7.  Hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with cortisol.

Authors:  J R Hodges; J Sadow
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

8.  Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy.

Authors:  J A Hicklin; M R Wills
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

9.  Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis.

Authors:  J R Daly; A B Myles; P A Bacon; C G Beardwell; O Savage
Journal:  Ann Rheum Dis       Date:  1967-01       Impact factor: 19.103

10.  Assay of corticotrophin in dexamethasone-treated rats.

Authors:  H D Purves; N E Sirett
Journal:  Endocrinology       Date:  1965-08       Impact factor: 4.736

View more
  3 in total

1.  The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.

Authors:  J C Buckingham
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

2.  The effects of ether stress and betamethasone treatment on the concentrations of noradrenaline and dopamine in various regions of the rat brain.

Authors:  S V Vellucci
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

3.  Corticotroph isolation from Pomc-eGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis.

Authors:  Peter J Duncan; Heather McClafferty; Oscar Nolan; Qinghui Ding; Natalie Z M Homer; Paul Le Tissier; Brian R Walker; Michael J Shipston; Nicola Romanò; Thomas J G Chambers
Journal:  J Neuroendocrinol       Date:  2022-07-14       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.